UnitedHealth Group Incorporated
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at UnitedHealth Group Incorporated.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 259.00 $ to 436.40 $ · Last price: 375.20 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Healthcare Plans
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Incorporated UNH | 338.6 | 29.6 | 14.9 | 19.7 | 8.1 | 11.8 | 12.8 |
| CVS Health Corp CVS | 115.6 | 40.1 | 13.7 | 13.6 | 4.1 | 7.9 | 25.9 |
| Elevance Health Inc ELV | 89.9 | 17.7 | 0.0 | 26.0 | 5.3 | 12.6 | 37.0 |
| Cigna Corp CI | 72.8 | 11.9 | 7.7 | 9.1 | 5.5 | 11.3 | -4.8 |
| Humana Inc HUM | 46.3 | 41.8 | 0.0 | 13.7 | 4.7 | 10.1 | 43.3 |
| Centene Corp CNC | 33.1 | – | 3.9 | 11.4 | 5.1 | 19.4 | 107.6 |
| Molina Healthcare Inc MOH | 10.7 | 59.7 | 16.7 | 8.4 | 1.7 | 11.8 | 16.3 |
| Oscar Health Inc OSCR | 9.2 | – | 0.0 | 20.2 | 15.2 | 27.5 | 80.0 |
| Clover Health Investments Corp CLOV | 2.4 | – | -0.6 | 18.5 | 3.7 | 40.3 | 47.9 |
| Median of companies shown | 46.3 | 34.9 | 3.9 | 13.7 | 5.1 | 11.8 | 37.0 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 184,840 | 12,930 | 7,017 | 7.25 | 9,795 | 38,397 | 122,679 |
| 2017 | 201,159 | 15,209 | 10,558 | 10.72 | 13,596 | 49,833 | 139,057 |
| 2018 | 226,247 | 17,344 | 11,986 | 12.19 | 15,713 | 51,696 | 152,221 |
| 2019 | 242,155 | 19,685 | 13,839 | 14.33 | 18,463 | 57,616 | 173,889 |
| 2020 | 257,141 | 22,405 | 15,403 | 16.03 | 22,174 | 65,491 | 197,289 |
| 2021 | 287,597 | 23,970 | 17,285 | 18.08 | 22,343 | 71,760 | 212,206 |
| 2022 | 324,162 | 28,435 | 20,120 | 21.18 | 26,206 | 77,772 | 245,705 |
| 2023 | 371,622 | 32,358 | 22,381 | 23.86 | 29,068 | 88,756 | 273,720 |
| 2024 | 400,278 | 32,287 | 14,405 | 15.51 | 24,204 | 92,658 | 298,278 |
| 2025 | 447,567 | 18,964 | 12,056 | 13.25 | 19,697 | 94,110 | 309,581 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 5.98 | 2.50 | 100,807 | 6.80 | 5.50 | 2,369 | 1,457 |
| 2025: Q1 | 6.85 | – | 109,575 | 9.80 | 5.70 | 5,456 | 4,558 |
| 2025: Q2 | 3.74 | -17.60 | 111,616 | 12.90 | 3.10 | 7,188 | 6,302 |
| 2025: Q3 | 2.57 | -60.50 | 113,161 | 12.20 | 2.10 | 5,945 | 5,055 |
| 2025: Q4 | 0.01 | -99.80 | 113,215 | 12.30 | 0.00 | 1,108 | 160 |
| 2026: Q1 | 6.90 | 0.70 | 111,721 | 2.00 | 5.60 | 8,912 | 8,149 |
| 2026: Q2 | 6.04 | 61.50 | 112,032 | 0.40 | 4.90 | 11,052 | 10,253 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 3 of our scanner strategies — each hit links to the scanner.
Aktien.Guide
Dividends
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 19.81 | 18.40 – 20.11 | 446,534 | 21.2% | 25 |
| 12/31/2027 | 22.44 | 19.92 – 24.50 | 459,362 | 13.2% | 27 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly 3.2% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $23.62B |
|---|---|
| Market cap | $338.59B |
| Free cash flow in year ten | $32.23B |
| Terminal value as a share of market value | 50.2% |
For comparison: over the past five years free cash flow shrank by 4.4% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 11.4%
- More than 10% revenue growth is expected for the coming year 2.7%
- Share count grows by less than 3% a year -1.4%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 15.4%
- Gross margin at 40% or higher and without meaningful erosion 18.5%
- Goodwill from acquisitions does not grow faster than revenue 35.7%
- Net debt below twice EBITDA 2.2 x EBITDA
- Operating cash flow covers the profits of the last three years 24,127 m
- Return on capital at 15% or higher, or up versus two years ago 9.7%
- Insiders hold at least 10% or are net buyers 0.2%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
6/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 10.3%
- Exp. sales growth 3Y > 5% 1.3%
- EBIT growth 10Y > 5% 4.3%
- Exp. EBIT growth 3Y > 5% 30.1%
- Net debt < 4x EBIT 2.7x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 41.4%
- Return on equity > 15% –
- ROCE > 15% 9.7%
- Expected return > 10% 36.3%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | DeVeydt Wayne S | Chief Financial Officer | Other | 1,209 | 399.66 | 483,189 |
| Aug 21, 2026 | Conway Patrick Hugh | Chief Executive Officer, Optum | Sell | 1,169 | 390.00 | 455,910 |
| Aug 11, 2026 | Stankiewicz Dennis Andrew | Chief Accounting Officer | Other | 233 | 402.19 | 93,710 |
| Aug 5, 2026 | Conway Patrick Hugh | Chief Executive Officer, Optum | Sell | 500 | 410.00 | 205,000 |
The company
About the Company
UnitedHealth Group Incorporated ist ein Gesundheitsunternehmen mit Geschäft in den USA und international. Es ist in vier Segmenten tätig: Optum Health, Optum Insight, Optum Rx und UnitedHealthcare.
- Employees
- 390,000
- Headquarters
- Eden Prairie, MN
- Address
- 1 Health Drive, 55344 Eden Prairie, United States
- Phone
- (800)-328-5979
- Website
- unitedhealthgroup.com
- IPO Date
- 10/26/1984
- ISIN
- US91324P1021
- Stock Split
- 2:1 on 05/31/2005
- Stock Split
- 2:1 on 06/19/2003
- Stock Split
- 2:1 on 12/26/2000
Management
| Name | Title | Birth Year |
|---|---|---|
| Stephen J. Hemsley | CEO & Non-Independent Non-Executive Chairman | 1953 |
| Wayne Scott DeVeydt | Chief Financial Officer | 1970 |
| Christopher R. Zaetta | Executive VP, Chief Legal Officer & Corporate Secretary | 1972 |
| Timothy John Noel | Chief Executive Officer of UnitedHealthcare Business | 1972 |
| Patrick Hugh Conway M.D., M.Sc. | Chief Executive Officer of Optum | 1975 |
| Dennis Stankiewicz | Chief Accounting Officer & Corporate Controller | 1978 |
| Sandeep Dadlani | Executive VP and Chief Digital & Technology Officer | 1975 |
| Zachary William Sopcak | Senior Vice President of Capital Markets Communications & Investor Relations | – |
| Erin L. McSweeney J.D. | Executive VP & Chief People Officer | 1965 |
| Richard J. Migliori M.D. | Executive Vice President & Senior Advisor | 1957 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.